⚖️ Weight regain after OAGB – what now?
In a 2-centre series (64 pts), TORe led to ~8% TBWL at 12 months with a 97% safety rate, but 17% needed additional treatments.
👉 A moderately effective, endoscopic option that still needs long-term data. 🔗🩺 https://t.co/GnDuarZyeK
💥 New data on distal pancreatectomy!
Targeted use of TachoSil®️ reduces postpancreatectomy haemorrhage – especially in patients who develop POPF – without changing POPF rates.
👉 “Selective use over one-size-fits-all” in pancreatic surgery. 🩸🔬 https://t.co/447Qb5UZKA
🚨 New data on SDD in gastric cancer #surgery!
In a matched cohort of 108 gastrectomy patients, SDD showed no reduction in infections — but higher pneumonia rates and resistant isolates.
Routine use? Questionable.
👉 https://t.co/aHHsxpILtj
#GastricCancer#Surgery#SDD
🚨 News from Aachen!
How well can we predict kidney graft function 1 year after deceased donor transplantation?
🔍 The original prognostic model reliably identifies poor graft outcomes
⚙️ Recalibration improves prediction across all eGFR categories
👉 https://t.co/DiFpVmUvzD
🩺📊 Diarrhea after pancreatic surgery by @UllaKlaiber et al.
👉 Affects 22% of patients
👉 Highest risk: total pancreatectomy (35%) & vascular resections (up to 87%)
🏥 Leads to longer hospital stay
#Surgery#Pancreas
👉 Check it out: https://t.co/u86q3E4TBJ
🇨🇭🔪 Switzerland trains more doctors – but fewer ops per surgeon!
👩⚕️ Surgical workforce +50% by 2040
⚠️ Yet: declining complex cases per visceral surgeon → training at risk!
👉 Adapting pathways & practice models is key
👉🏻 https://t.co/JSwPu0AFft
🔬 New study shows: Intraoperative optical coherence tomography (OCT) may improve differentiation of #pancreatic tumors—from benign to malignant! 💡 👨⚕️ First ex vivo results are promising. 🧠 Merging histology with cutting-edge imaging.
➡️ https://t.co/d4F1cYiG6W
🎗️ July is Sarcoma Awareness Month
🔬 Focus on retroperitoneal sarcoma:
🪡 Surgery is key
📊 5-yr OS: 63.5% | DFS: 35.3%
📉 Worse outcomes with high FNCLCC grade & positive margins
https://t.co/boyPZCjbTH
#SarcomaAwareness#Oncology#Surgery
🧵 NOVOTILAC RCT
Chlorhexidine-coated vs. non-coated sutures in preventing surgical site infections (SSI) after laparoscopic surgery
323 patients:
SSI rate: 5% (coated 3.79% vs non-coated 6.17%)
Do you think antimicrobial sutures should be the standard?
https://t.co/avOdRTPdgS
Intra- 🧵 vs. Extracorporeal ✂️ anastomosis in minimally invasive right hemicolectomy with CME:
✅ Fewer infections (0% vs. 3%)
✅ Less pain on POD 4
✅ Faster bowel recovery (POD 2 vs. POD 3)
✅ Enhanced recovery
📈 No difference in major complications
🔗 https://t.co/2E8g7XrKJS
🩺 @fmhaak et al. explored the digital standardization in #liversurgery using Surgical Workflow #Management Systems:
⏳No reduction in deviations from planned surgery duration
😌Stress levels of the operating team unaffected
Interested? https://t.co/8HMO0c0EMc
Does very high alpha-fetoprotein (AFP) affect very early hepatocellular carcinoma (#HCC) outcomes after #liverresection?
⏳No difference in long-term disease-free survival (DFS) or overall survival (OS) between high and low AFP groups
Check it out: https://t.co/IN4NNmdjsT
🦵 Early Knee Osteoarthritis (KOA)? A new study highlights the benefits of combining Arthroscopic Cartilage Transplantation with Platelet-Rich Plasma (ACT-PRP):
Better knee function 🏃♂️
Significant pain relief 💊
Higher patient satisfaction 😊
🌟 Read more: https://t.co/yQkz58cwqt
To drain or not to drain in minimally invasive ventral #hernia surgery?
No significant difference in postop complications between drain and no-drain groups
📏Larger defect sizes in drain group
🤖 Robotic surgeries more likely to use drains
Interested? https://t.co/FJpJfn9dcu
Our Editor-in-Chief @ProbstPascal and Martin Wagner ask in their latest article: “Who do you trust?” — levels of evidence in the AI era:
🤖 AI challenges evidence hierarchies
🔑 Transparency & reproducibility remain key
🌟 Check it out https://t.co/PgOhY9kymY